INTERVIEW WITH PROFESSOR EVANDRO DE AZAMBUJA
‘WE NEED A PAN-EUROPEAN APPROACH TO CANCER CARE IN THE SETTING OF THE COVID-19 PANDEMIC’
Patients with COVID-19 who have an underlying malignancy, have a higher mortality rate compared with those without cancer, although the magnitude of such excess risk is not clearly defined. A systematic review and pooled analysis of 52 studies involving 18,650 patients with both COVID-19 and cancer, revealed that 4,243 deaths were recorded among this population, equating a probability of death of 25,6%. Professor Evandro de Azambuja was one of the authors of this study… Read more
ANTICANCER THERAPIES & COVID-19 WITH COMMENT OF ONCOLOGIST KEVIN PUNIE
ASSOCIATIONS BETWEEN CLINICAL FACTORS AND RECENT ANTICANCER THERAPIES IN PATIENTS WITH CANCER AND COVID-19
Patients with cancer may be at high risk of adverse outcomes from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Petros Grivas and colleagues analyzed a cohort of patients with cancer and COVID-19 reported to the COVID-19 and Cancer Consortium (CCC19) to identify prognostic clinical factors, including laboratory measurements and anticancer therapies… Read more
INTERVIEW WITH MAARTEN VAN HERCK, PHD, MAASTRICHT UNIVERSITY
ALL YOU NEED TO KNOW ABOUT ‘LONG COVID’ AND ITS IMPACT ON HAEMATOLOGICAL AND CANCER PATIENTS
In May 2020, when more and more COVID-19 patients reported a vast array of long lasting symptoms, Hasselt University together with Maastricht University and the Center of Expertise for Chronic Organ Failure (CIRO) was among the first in Europe to investigate this. Now, almost one year later, Van Herck shares his knowledge on what has become known as LONG-COVID… Read more
INTERVIEW WITH ANNA ROUKENS, MD, PHD, LEIDEN UNIVERSITY
VACCINATING INTO SKIN INSTEAD OF MUSCLES COULD MEAN MANY MORE PEOPLE CAN BE IMMUNIZED
The current COVID-19 vaccination campaign involves injecting the vaccine into muscle tissue, but injecting a smaller amount of vaccine in the skin might also provide good protection. A crowdfunding campaign has enabled Dutch infectious disease specialist Anna Roukens MD, PhD, at the Leiden University Medical Centre (LUMC) to examine the safety and efficacy of vaccination delivery via the skin… Read more
Top
